Page 51 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

30 PART I The Biology and Pathogenesis of Cancer

172. Knapp DW, Peer WA, Conteh A, et al.: Detection of herbicides in 192. Bukowski JA, Wartenberg D: An alternative approach for investi-
the urine of pet dogs following lawn chemical application, Sci Total gating the carcinogenicity of indoor air pollution: pets as sentinels
Environ 456-457:34–41, 2013. of environmental cancer risk, Environ Health Perspect 105:1312–
VetBooks.ir 173. Glickman LT, Schofer FS, McKee LJ, et al.: Epidemiologic study 193. Hargis AM: A review of solar-induced lesions in domestic animals,
1319, 1997.
of insecticide exposures, obesity, and risk of bladder cancer in
household dogs, J Toxicol Environ Health 28:407–414, 1989.
Comp Cont Edu 3:287–294, 1981.
174. Knapp DW, Glickman NW, Denicola DB, et al.: Naturally-occur- 194. Dorn CR, Taylor DON, Schneider R, et al.: Survey of animal
ring canine transitional cell carcinoma of the urinary bladder: a neoplasms in Alameda and Contra Costa Counties, California. II.
relevant model of human invasive bladder cancer, Urol Oncol 5:47– Cancer morbidity in dogs and cats from Alameda County, J Natl
59, 2000. Cancer Inst 40:307–318, 1968.
175. Glickman LT, Raghavan M, Knapp DW, et al.: Herbicide expo- 195. Schaffer PA, Wobeser B, Martin LE, et al.: Cutaneous neoplastic
sure and the risk of transitional cell carcinoma of the urinary blad- lesions of equids in the central United States and Canada: 3,351
der in Scottish Terriers, J Am Vet Med Assoc 224:1290–1297, 2004. biopsy specimens from 3,272 equids (2000-2010), J Am Vet Med
176. Raghavan M, Knapp DW, Dawson MH, et al.: Topical flea and Assoc 242:99–104, 2013.
tick pesticides and the risk of transitional cell carcinoma of the uri- 196. Anderson DE, Badzioch M: Association between solar radiation
nary bladder in Scottish Terriers, J Am Vet Med Assoc 225:389–394, and ocular squamous cell carcinoma in cattle, Am J Vet Res 52:784–
2004. 788, 1991.
177. Baker GL, Kahl LE, Zee BC, et al.: Malignancy following treat- 197. Madewell BR, Conroy JD, Hodgkins EM: Sunlight-skin can-
ment of rheumatoid arthritis with cyclophosphamide. Long-term cer association in the dog: a report of three cases, J Cutan Pathol
case-control follow-up study, Am J Med 83:1–9, 1987. 8:434–443, 1981.
178. Weller RE, Wolf AM, Oyejide A: Transitional cell carcinomas of 198. Saridomichelakis MN, Day MJ, Apostolidis KN, et al.: Basal cell
the bladder associated with cyclophosphamide therapy in a dog, J carcinoma in a dog with chronic solar dermatitis, J Small Anim
Am Anim Hosp Assoc 15:733–736, 1979. Pract 54:108–111, 2013.
179. Macy DW, Withrow SJ, Hoopes J: Transitional cell carcinoma of 199. Miller MA, Nelson SL, Turk JR, et al.: Cutaneous neoplasia in 340
the bladder associated with cyclophosphamide administration, J cats, Vet Pathol 28:389–395, 1991.
Am Anim Hosp Assoc 19:965–969, 1983. 200. Fu W, Cocherell CJ: The actinic (solar) keratosis: a 21st-century
180. Cox PJ: Cyclophosphamide cystitis—identification of acrolein as perspective, Arch Dermatol 139:66–70, 2003.
the causative agent, Biochem Pharmacol 28:2045–2049, 1979. 201. Khan SG, Bickers DR, Mukhtar H, et al.: Ras p21 farnesylation in
181. Matz EL, Hsieh MH: Review of advances in uroprotective agents ultraviolet B radiation - induced tumors in the skin of SKH-1 hair-
for cyclophosphamide- and ifosfamide-induced hemorrhagic cysti- less mice, J Invest Dermatol 102:754–758, 1994.
tis, Urology 100:16–19, 2017. 202. Lowe NJ, Weingarten D, Wortzman M: Sunscreens and phototest-
182. Monach PA, Arnold LM, Merkel PA: Incidence and prevention ing, Clin Dermatol 6:40–49, 1988.
of bladder toxicity from cyclophosphamide in the treatment of 203. Hanahan D, Weinberg RA: Hallmarks of cancer: the next genera-
rheumatic diseases: a data-driven review, Arthritis Rheum 62:9–21, tion, Cell 144:646–674, 2011.
2010. 204. Bernays ME, Flemming D, Peiffer Jr RL: Primary corneal papil-
183. Harper A, Blackwood L: Toxicity of metronomic cyclophospha- loma and squamous cell carcinoma associated with pigmentary
mide chemotherapy in a UK population of cancer-bearing dogs: a keratitis in four dogs, J Am Vet Med Assoc 214:215–217, 1999.
retrospective study, J Small Anim Pract 58:227–230, 2017. 205. Hakanson N, Shively JN, Reed RE: Intraocular spindle cell sar-
184. Matsuyama A, Schott CR, Wood GA, et al.: Evaluation of metro- coma following ocular trauma in a cat: case report and literature
nomic cyclophosphamide chemotherapy as maintenance treatment review, J Am Anim Hosp Assoc 26:63–66, 1990.
for dogs with appendicular osteosarcoma following limb amputa- 206. Dickinson R, Bauer B, Gardhouse S, et al.: Intraocular sarcoma
tion and carboplatin chemotherapy, J Am Vet Med Assoc 252:1377– associated with a ruptured lens in a rabbit (Oryctolagus cuniculus),
1383, 2018. Vet Ophthalmol 16(Suppl 1):168–172, 2013.
185. Best MP, Fry DR: Incidence of sterile hemorrhagic cystitis in dogs 207. Wertheimer N, Leeper E: Electrical wiring configurations and
receiving cyclophosphamide orally for three days without concur- childhood cancer, Am J Epidemiol 109:273–284, 1979.
rent furosemide as part of a chemotherapeutic treatment for lym- 208. Reif JS, Lower KS, Ogilvie GK: Residential exposure to magnetic
phoma: 57 cases (2007-2012), J Am Vet Med Assoc 243:1025–1029, fields and risk of canine lymphoma, Am J Epidemiol 141:352–359,
2013. 1995.
186. Charney SC, Bergman PJ, Hohenhaus AE, et al.: Risk factors for 209. National Research Council (US): Committee on the Possible Effects
sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclo- of Electromagnetic Fields on Biologic Systems, Possible health effects of
phosphamide with or without concurrent administration of furose- exposure to residential electric and magnetic fields, Washington, DC,
mide: 216 cases (1990-1996), J Am Vet Med Assoc 222:1388–1393, 1997, National Academies Press.
2003. 210. Thrall DE: Orthovoltage radiotherapy of acanthomatous epulides
187. Mutsaers AJ, Widmer WR, Knapp DW: Canine transitional cell in 39 dogs, J Am Vet Med Assoc 184:826–829, 1984.
carcinoma, J Vet Intern Med 17:136–144, 2003. 211. McEntee MC, Page RL, Théon A, et al.: Malignant tumor forma-
188. Reif JS, Cohen D: The environmental distribution of canine respi- tion in dogs previously irradiated for acanthomatous epulis, Vet
ratory tract neoplasms, Arch Environ Health 22:136–140, 1971. Radiol Ultrasound 45:357–361, 2004.
189. Hayes HM, Hoover R, Tarone RE: Bladder cancer in pet dogs: a 212. Kuttesch JF, Wexler LH, Marcus RB, et al.: Second malignancies
sentinel for environmental cancer? Am J Epidemiol 114:229–233, after Ewing’s sarcoma: radiation dose-dependency of secondary
1981. sarcomas, J Clin Oncol 14:2818–2825, 1996.
190. Van Der Schalie WH, Gardner Jr HS, Bantle JA, et al.: Animals 213. Hall EJ, Wuu CS: Radiation-induced second cancers: the impact
as sentinels of human health hazards of environmental chemicals, of 3D-CRT and IMRT, Int J Radiat Oncol Biol Phys 56:83–88,
Environ Health Perspect 107:309–315, 1999. 2003.
191. Bukowski JA, Wartenberg D, Goldschmidt M: Environmen- 214. Suit H, Goldberg S, Niemierko A, et al.: Secondary carcinogenesis
tal causes for sinonasal cancers in pet dogs, and their usefulness in patients treated with radiation: a review of data on radiation-
as sentinels of indoor cancer risk, J Toxicol Environ Health Part A induced cancers in human, non-human primate, canine and rodent
54:579–591, 1998. subjects, Radiat Res 167:12–42, 2007.